Evidence map›Paper›PMID 32748178›Full record

ArticleArchives of virology2020

Characterization of two newly isolated Staphylococcus aureus bacteriophages from Japan belonging to the genus Silviavirus.

Naoya Kitamura, Eri Sasabe, Shigenobu Matsuzaki, Masanori Daibata, Tetsuya Yamamoto

Open access · hybridAbstract read
In one paragraph

Article in Archives of virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Characterization and genomic analysis of aFrontiers in microbiology · 2025
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Naoya KitamuraDepartment of Oral and Maxillofacial Surgery, Kochi Medical School, Kochi University, Nankoku, Kochi, 783-8505, Japan. nkitamura@kochi-u.ac.jp.ORCID http://orcid.org/0000-0001-9683-6002
Eri SasabeDepartment of Oral and Maxillofacial Surgery, Kochi Medical School, Kochi University, Nankoku, Kochi, 783-8505, Japan.
Shigenobu MatsuzakiDepartment of Microbiology and Infection, Kochi Medical School, Kochi University, Nankoku, Kochi 783-8505, Japan.
Masanori DaibataDepartment of Microbiology and Infection, Kochi Medical School, Kochi University, Nankoku, Kochi 783-8505, Japan.
Tetsuya YamamotoDepartment of Oral and Maxillofacial Surgery, Kochi Medical School, Kochi University, Nankoku, Kochi, 783-8505, Japan.
Kōchi University · JP

Funding

the Japan Society for the Promotion of Science 1 a Grant-in-Aid for Scientific Research (C) 8K09793
6 · The paper itself

Abstract

Two Staphylococcus aureus bacteriophages, KSAP7 and KSAP11, were isolated from sewage and characterized. Based on morphology and DNA sequences, they were assigned to the genus Silviavirus, subfamily Twortvirinae, family Herelleviridae, whose members are hypothesized to be suitable for bacteriophage therapy. The KSAP7 and KSAP11 genomes were 137,950 and 138,307 bp in size, respectively. Although their DNA sequences were almost identical, evidence of site-specific DNA rearrangements was found in two regions. Changes in the number of PIEPEK amino acid sequence repeats encoded by orf10 and the insertion/deletion of a 541-bp sequence that includes a possible tail-related gene were identified.

Indexed as

Genome, ViralPhylogenyAmino Acid SequenceCaudoviralesDNA, ViralGene RearrangementGenome SizeINDEL MutationJapanOpen Reading FramesPhage TherapySequence AlignmentStaphylococcus aureusStaphylococcus PhagesDNA, Viral

Identifiers

PMID32748178
PMCPMC7497331
OpenAlexW3048337608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.